Abstract:SC35 is a member of serine/arginine rich protein of splicing factors. It plays very important role in alternative splicing of pre-mRNAs. Tau is the major neuronal microtubule-associated protein. Its abnormally hyperphosphorylation and aggregation into neurofibrillary tangles is a characteristic of tauopathies, including Alzheimer's disease. In adult human brain, six tau isoforms are expressed from a single gene by alternative splicing of exons 2, 3, and 10. Alternative splicing of exon 10 generates tau isoforms with either three or four microtubule-binding repeats (3R- or 4R-tau). Normal human expresses equal levels of 3R-tau and 4R-tau. Dysregulation of E10 10 causes tauopathies, such as frototemporal dementia with Parkinsonism linked with chromosome 17, progressive supranuclear palsy, Pick's disease, and corticobasal degeneration, suggesting that the balance of 3R-tau and 4R-tau is critical for normal function of brain. We cotransfected mini-tau gene, consisting of exons 9, 10, 11, a part of intron 9 and full length of intron 10 with same amount of pCEP4/SC35 plasmids into HEK-293T cells and detected E10 splicing by using RT-PCR. To test whether SC35 is phosphorylated by PKA, we phosphorylated GST-SC35 in vitro by PKA. To map the phosphorylation sites, we constructed deletion mutations of SC35 and then phosphorylated them with PKA. To learn whether PKA affects the function of SC35 in tau E10 splicing, we found SC35 significantly promoted tau E10 inclusion, resulting in an increase in 4R-tau production. Dyrk1A (dual-specificity tyrosine phosphorylation-regulated kinase 1A), coded by a gene located at the Down syndrome critical region, interacted with SC35 in vitro and in vivo and phosphorylated it efficiently. Overexpression of Dyrk1A in HEK-293T cells significant inhibited tau E10 inclusion promoted by SC35. In Down syndrome brain, Dyrk1A is overexpressed due to trisomy 21 and 3R/4R tau ratio is increased. Dyrk1A inhibits SC35-promoted tau E10 inclusion by phosphorylating SC35. Imbalance of 3R-tau and 4R-tau induced by Dyrk1A overexpression might contribute to neurofibrillary degeneration in Down syndrome.

Sirt1 Deacetylates Sc35 And Suppresses Its Function In Tau Exon 10 Inclusion

Sirt1 Enhances Tau Exon 10 Inclusion And Improves Spatial Memory Of Htau Mice

Regulation of the Alternative Splicing of Tau Exon 10 by SC35 and Dyrk1A

P1‐351: Splicing Factor SC35 Regulates the Alternative Splicing of Tau Exon 10

Splicing factor SC35 regulates the alternative splicing of tau exon 10

Defects in the autophagy lysosomal pathway in a cell model of disease‐associated tau

Resveratrol Regulates the Alternative Splicing of Tau Exon 10 to Improve Learning and Memory in Htau Mice

Cyclic AMP-Dependent Protein Kinase Enhances SC35-Promoted Tau Exon 10 Inclusion

PP1 REGULATES THE ALTERNATIVE SPLICING OF TAU EXON 10 THROUGH SPLICING FACTOR SC35

SIRT1 deficiency increases O-GlcNAcylation of tau, mediating synaptic tauopathy

SIRT1 regulates O-GlcNAcylation of tau through OGT.

P2-155: Phosphorylation of SC35 by Dyrk1A inhibits its promotion of tau exon 10 inclusion

Cyclic AMP-dependent Protein Kinase Regulates the Alternative Splicing of Tau Exon 10: A MECHANISM INVOLVED IN TAU PATHOLOGY OF ALZHEIMER DISEASE

SIRT1 Involved in the Regulation of Alternative Splicing Affects the DNA Damage Response in Neural Stem Cells.

Srp54 (sfrs11), A Regulator for Tau Exon 10 Alternative Splicing Identified by an Expression Cloning Strategy

Cyclic AMP-dependent protein kinase regulates 9G8-mediated alternative splicing of tau exon 10.

A disease-causing intronic point mutation C19G alters tau exon 10 splicing via RNA secondary structure rearrangement.

Dysregulation of RNA Splicing in Tauopathies.

Cooperative effects of SIRT1 and SIRT2 on APP acetylation

Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (Asf)-Regulated Alternative Splicing of Tau in Down Syndrome

The beneficial role of SIRT1 in preventive or therapeutic options of Neurodegenerative Diseases